The sleep inducing brain lipid cis-oleamide (cOA) does not modulate serotonergic transmission in the CA1 pyramidal neurons of the hippocampus in vitro

被引:6
作者
Dougalis, A
Lees, G
Ganellin, CR
机构
[1] Univ Sunderland, Sch Hlth Social & Nat Sci, Sunderland Pharm Sch, Sunderland SR1 3SD, Durham, England
[2] UCL, Christopher Ingold Labs, Dept Chem, London WC1H 0AJ, England
基金
英国惠康基金;
关键词
cis-oleamide; cis-9; 10; octadeceneoamide; scrotonin; hippocampus; 5-HT1A and 5-HT2 receptors; sleep;
D O I
10.1016/S0028-3908(03)00297-1
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
cis-Oleamide (cOA) is a novel sleep inducing brain lipid with an unknown mechanism of action. High affinity interactions with metabotropic 5-HT receptors (2A/C and 1A subtypes) in frog oocytes and expression systems have been reported, but functional in vitro evidence for the modulatory effect is still lacking. Here, we addressed the ability of cOA to modulate 5-HT-induced cellular actions in the CA1 neurons of the rat hippocampal slice. 5-HT (0.1-100 muM) concentration dependently reduced the amplitude of the evoked field population spike (fPS), and produced a hyperpolarising shift in the resting membrane potential (V-r) and a drop in input resistance (R-in). The effects of a low dose of 5HT (3.2 muM) on fPS, V-r and R-in were reversed by the specific 5-HT1A-receptor antagonist WAY 100135 (10 muM). cOA (1 muM) failed to potentiate 5-HT1A receptor mediated effects on fPS, V-r or R-in. High doses of 5-HT also recruited both 5-HT2 and 5-HT3 receptors, causing an increase in the rate and amplitude of sIPSCs. cOA (1 muM), in the presence of Y 25130, failed to potentiate the 5-HT, receptor induced enhancement of sIPSCs. In summary, cis-oleamide failed to modulate metabotropic responses to exogenous 5-HT in this microelectrode study at concentrations well in excess of those reported to modulate 5-HT1A and 5-HT2A/C systems in earlier studies. (C) 2003 Elsevier Ltd. All rights reserved.
引用
收藏
页码:63 / 73
页数:11
相关论文
共 53 条
[1]   The LTP Program: a data acquisition program for on-line analysis of long-term potentiation and other synaptic events [J].
Anderson, WW ;
Collingridge, GL .
JOURNAL OF NEUROSCIENCE METHODS, 2001, 108 (01) :71-83
[2]   PHARMACOLOGICALLY DISTINCT ACTIONS OF SEROTONIN ON SINGLE PYRAMIDAL NEURONS OF THE RAT HIPPOCAMPUS RECORDED INVITRO [J].
ANDRADE, R ;
NICOLL, RA .
JOURNAL OF PHYSIOLOGY-LONDON, 1987, 394 :99-124
[3]  
ANDRADE R, 1991, J PHARMACOL EXP THER, V257, P930
[4]   Characterization of the hypnotic properties of oleamide [J].
Basile, AS ;
Hanus, L ;
Mendelson, WB .
NEUROREPORT, 1999, 10 (05) :947-951
[5]   5-CARBOXYAMIDOTRYPTAMINE MIMICS ONLY THE 5-HT ELICITED HYPERPOLARIZATION OF HIPPOCAMPAL PYRAMIDAL CELLS VIA 5-HT1A RECEPTOR [J].
BECK, SG .
NEUROSCIENCE LETTERS, 1989, 99 (1-2) :101-106
[6]  
BENNETT JP, 1976, MOL PHARMACOL, V12, P373
[7]   WHOLE CELL RECORDING FROM NEURONS IN SLICES OF REPTILIAN AND MAMMALIAN CEREBRAL-CORTEX [J].
BLANTON, MG ;
LOTURCO, JJ ;
KRIEGSTEIN, AR .
JOURNAL OF NEUROSCIENCE METHODS, 1989, 30 (03) :203-210
[8]   Pharmacological differentiation between neuronal and recombinant glutamate receptor channels expressed in Xenopus oocytes [J].
Blaschke, M ;
Gremmels, D ;
Everts, I ;
Weigand, E ;
Heinemann, SF ;
Hollmann, M ;
Keller, BU .
NEUROPHARMACOLOGY, 1997, 36 (11-12) :1489-1501
[9]   Structural requirements for 5-HT2A and 5-HT1A serotonin receptor potentiation by the biologically active lipid oleamide [J].
Boger, DL ;
Patterson, JE ;
Jin, Q .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (08) :4102-4107
[10]  
Boger DL, 1998, CURR PHARM DESIGN, V4, P303